Explore more publications!

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

Press releases published on January 27, 2026

Addiction Treatment Center Warns About Staggering Untreated Addiction Rates in Oklahoma
Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation
Organizations Join Forces to Map How Human Muscle Regenerates
Bicycle Health Appoints Rick Dean as Chief Executive Officer to Lead Next Phase of Growth
Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Imprivata Pledges Support for CMS “Kill the Clipboard” Initiative to Simplify and Secure Patient Access to Medical Records
Global Clinical Mass Spectrometry Market to Reach USD 3.31 Billion by 2031 | MarketsandMarkets™
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
TRIMEDX named recipient of Modern Healthcare’s Best in Business Award in Cybersecurity category
Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma
SRx Health Solutions Allocates Further Capital to its Digital Asset Treasury Hedging Strategy, Bringing Total Allocation to $18 Million
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer
NewGen to Execute Up to US$2 Million Share Repurchase Program Through Benchmark
Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering
ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions